Refill Kit 8551/856X (includes Models 8561, 8562 and 8564) for use with Medtronic Implantable Pro...

FDA Device Recall #Z-1568-2014 — Class II — April 4, 2014

Recall Summary

Recall Number Z-1568-2014
Classification Class II — Moderate risk
Date Initiated April 4, 2014
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Medtronic Neuromodulation
Location Minneapolis, MN
Product Type Devices
Quantity 13,784

Product Description

Refill Kit 8551/856X (includes Models 8561, 8562 and 8564) for use with Medtronic Implantable Programmable Infusion Pumps. Product Usage: The Refill Kits are intended for use in refilling Medtronic programmable, implantable infusion pumps with the exception of Medtronic MiniMed infusion pumps.

Reason for Recall

Some refill kits in the affected lots may contain an extension tubing set that is occluded and healthcare professionals may be unable to aspirate or fill the SynchroMed pumps. There is no problem with the Lioresal Intrathecal (baclofen injection) contained in the affected drug refill kits. There have been no patient injuries beyond additional needle sticks associated with this issue.

Distribution Pattern

Worldwide Distribution - USA Nationwide in the states of NM, ND, RI, and VT and the countries of Australia, Singapore, Thailand, Central and Eastern Europe, Western Europe, Middle East, & Panama.

Lot / Code Information

Lot numbers CS3643, CS3613, CS3663, N441998, N442081, N442131, N440259, N440527, N440582, N440654, N440909, N440978, N441199, N441268, N441806, N441817, N442178, N442513, N442532, N442560, N442588, N442831, and N443427. Affected lots were distributed between January 2014 and March 2014.

Other Recalls from Medtronic Neuromodulation

Recall # Classification Product Date
Z-1043-2026 Class II A71200 Vanta" Clinician Programmer Application ... Dec 3, 2025
Z-0996-2026 Class II Restore Clinician Programmer Application (CP Ap... Nov 20, 2025
Z-1704-2025 Class II Enhanced Verify Evaluation Handset (CFN HH90130FA) Apr 3, 2025
Z-1543-2025 Class II Stimulation RC Clinician Programmer Application... Mar 4, 2025
Z-1506-2025 Class II A820 myPTM Software Application associated with... Jan 9, 2025

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.